Tarsus Pharmaceuticals (TARS) Prices 5.71M Share Offering at $17.50/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Tarsus Announces Pricing of $100.0 Million Underwritten Public Offering of Common Stock
August 1, 2023 10:30 PM EDTIRVINE, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the Company or Tarsus), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the pricing of an underwritten public offering of 5,714,285 shares of its common stock at a public offering price of $17.50 per share, before underwriting discounts and commissions. In addition, Tarsus has granted the underwriters a 30-day option to purchase up to an additional 857,142 shares of common stock at the public offering price, less underwriting... More
